Hospira Pamidronate Disodium Injection 90 mg/10 mL vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

pamidronate disodium, Quantity: 9 mg/mL

Available from:

Hospira Australia Pty Ltd

INN (International Name):

pamidronate disodium

Pharmaceutical form:

Injection, concentrated

Composition:

Excipient Ingredients: sodium hydroxide; phosphoric acid; water for injections; mannitol

Administration route:

Intravenous Infusion

Units in package:

1 X 10 mL vial

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Hypercalcemia of Malignancy, pagets disease, osteolytic bone matastases of breast cancer and osteolytic lesions of multiple myeloma

Product summary:

Visual Identification: A clear, colourless solution free from visible particulates; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Listed (Export Only)

Authorization date:

2005-11-10